| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Enveric Biosciences GAAP EPS of -$0.61 | 2 | Seeking Alpha | ||
| Mi | Enveric Biosciences to out-license psilocin prodrug to MindBio | 4 | Pharmaceutical Technology | ||
| Mi | Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results | 34 | Business Wire | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule... ► Artikel lesen | |
| Mi | Enveric Biosciences, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| Mi | Enveric Biosciences, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Di | Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders | 178 | ACCESSWIRE | MindBio to develop the novel psilocin prodrug for neuropsychiatric indications utilizing microdosing to reduce or eliminate hallucinogenic impact of psychedelic compoundsVANCOUVER, BC / ACCESSWIRE /... ► Artikel lesen | |
| Di | Enveric Biosciences signs $66.5M non-binding term sheet with MindBio Therapeutics | 2 | Seeking Alpha | ||
| 10.05. | Enveric Biosciences Inc expected to post a loss of 77 cents a share - Earnings Preview | 2 | Reuters | ||
| 03.05. | Enveric Biosciences, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 03.04. | FibroGen, Acorda Therapeutics, Enveric Biosciences among healthcare movers | 15 | Seeking Alpha | ||
| 29.03. | Enveric Biosciences Inc reports results for the quarter ended in December - Earnings Summary | 4 | Reuters | ||
| 27.03. | Enveric Biosciences Inc expected to post a loss of $1.28 a share - Earnings Preview | 1 | Reuters | ||
| 27.03. | Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth | 4 | Benzinga.com | ||
| 26.03. | Enveric Biosciences reports Q4 results | 3 | Seeking Alpha | ||
| 26.03. | Enveric Biosciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 26.03. | Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023 | 106 | Business Wire | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule... ► Artikel lesen | |
| 19.03. | Why Is Anxiety/Addiction-Focused Enveric Biosciences Stock Trading Higher Tuesday? | 7 | Benzinga.com | ||
| 19.03. | Enveric Biosciences, Inc. - 8-K, Current Report | 7 | SEC Filings | ||
| 11.03. | Enveric Biosciences, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 29.02. | Why Is Enveric Biosciences (ENVB) Stock Up 120% Today? | 13 | InvestorPlace |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 390 |
| EVOTEC | 357 |
| TUI | 264 |
| NVIDIA | 218 |
| DEUTSCHE BANK | 209 |
| BAYER | 196 |
| NEL | 178 |
| PLUG POWER | 175 |
| RHEINMETALL | 166 |
| SIEMENS ENERGY | 150 |
| COMMERZBANK | 135 |
| BARRICK GOLD | 130 |
| TESLA | 125 |
| BASF | 124 |
| VOLKSWAGEN | 120 |
| DEUTSCHE LUFTHANSA | 113 |
| BYD | 111 |
| RWE | 109 |
| ALLIANZ | 107 |
| DEUTSCHE TELEKOM | 102 |
| MERCEDES-BENZ | 98 |
| RENK GROUP | 95 |
| ALIBABA | 93 |
| E.ON | 93 |
| REDCARE PHARMACY | 89 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
